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Terms of Reference for Joint HSE/ICGP Audit Review Group (ARG) – Methadone 
Treatment Protocol – (Revised and approved December 2011) 
Title: 
The committee will be known as the Joint HSE/ICGP Audit Review Group (ARG) 
Purpose: 
‘Our purpose is to provide support through advice, education, training and audit, to Level 1 and Level 
2 GPs, involved in treating people with substance misuse problems, so that the care provided meets 
the standards set out in national and international best practice guidelines’ 
Background: 
The Methadone Treatment Protocol (MTP) was implemented in October 1998. A joint ICGP and then 
ERHA audit review group was set up under the provision of the protocol. This group was given the 
remit of providing training, continuing medical education (CME) for GPs participating in the 
methadone protocol (page 56 Report of Methadone Treatment Services Review Group).  
As part of their contract of services with the Health Boards (now the HSE), GPs agree to participate 
in CME and annual external audit of their methadone patients. The ARG was given the task of 
devising a system of annual audit of the GPs participating in the Methadone Treatment Protocol. 
 
Function of ARG: 
 To devise and maintain a system of annual audit of GPs participating in the Methadone 
Treatment protocol 
 To have a representative from the ARG who will sit on and report to the Methadone 
Implementation  Committee 
 To issue certification on completion of satisfactory audit 
 To accept and process applications for level 2 accreditation 
 To provide ongoing review of audit and training requirements 
 
Accountability: 
The ARG reports internally to the ICGP Quality and Standards Committee. 
The ARG reports externally through the Service Level Agreement to the HSE. 
 
How members are appointed to the Committee:  





The committee is comprised of HSE representatives and ICGP representatives as detailed below: The 
positions are reviewed on a 2 year revolving cycle (next due for review January 2012). The group 
currently comprises of: 
Dr. John Cox (Chairperson) – nominated by ICGP 
Dr. Ide Delargy, Director, Substance Misuse Programme ICGP) – nominated by ICGP 
Dr. Des Crowley (GP Co-ordinator) – nominated by the HSE GP co-ordinator group 
Dr. Cliona Wilson (GP) – nominated by the ICGP 
Professor Joe Barry – Specialist in Public Health, nominated by the HSE 
Ms. Derval Howley  – nominated by the HSE 
Dr. Mike Scully – Consultant Psychiatrist in Substance Misuse - nominated by Consultant 
Psychiatrists Specialising in Substance Misuse 
Ms. Mary Fanning - (Clinical Audit Facilitator) 
Administrative Support: Niamh Killeen - ICGP 
 
Membership ceases: 
 When a person resigns from the committee 
 If a member breaches confidentiality 
 If member’s contract with HSE is terminated 
 
Duration of meetings: 
As determined by chairperson 
Frequency of Meetings:  
The ARG meets every 1 – 2 months depending on the number of audits required for review, 
minimum of four times a year. From time to time a subcommittee will be set up to review audits. 
This subcommittee is comprised of up to 4 members of the ARG and reports  to the full committee 
meeting.  
Arrangement for distribution of minutes:  
Minutes will be distributed by email 
 
 Communication Protocol:  
The process and confidentiality protocol for conducting the audits has been approved by the 
Research and Ethics Committee of the ICGP 
A GPs identity is coded for the purpose of discussion of audit results and only disclosed to the 
chairperson when communication from the committee is required. 
Decision Making Protocol:  
Decisions are made following a vote and a quorum of five is required. 
How often terms of reference are reviewed:  
Terms of reference are reviewed every two years when the membership of the committee is under 
review. 
